MCAS
October Newsletter: MCAS Month at Yoon Hang Kim MD (www.ifmsynergy.com)
October at IFM Synergy: fresh MCAS reading and a free academic chapter
MCAS
MCAS
Mast Cell Activation Syndrome (MCAS) v. Mastocytosis s
Yoon Hang Kim MD Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Important: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Mast cell disorders require individualized evaluation by qualified specialists. If you experience symptoms suggestive of anaphylaxis — airway compromise, hypotension,
rapamycine
Rapamycin (found in Rapa Nui or Easter Island) Beyond Transplant Medicine: Longevity, Mast Cell Activation Syndrome, and Autoimmune Disease Through a Functional Medicine Lens
Yoon Hang "John" Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Abstract Rapamycin (sirolimus), an mTOR inhibitor originally developed for transplant immunosuppression, has emerged as the most extensively studied pharmacologic candidate for mammalian lifespan extension and is now being explored for immune dysregulation conditions
amlexanox
Amlexanox for MCAS and Long COVID: What Does the Evidence Actually Show?
Amlexanox for MCAS and Long COVID: What Does the Evidence Actually Show?
ldn
One Medication, Three Conditions: Why LDN Is Not a Silver Bullet for Long COVID, ME/CFS, and MCAS
Endorphin Depletion, Immune Dysregulation, and the Limits of Pharmacological Optimism Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Introduction: The Allure of a Universal Solution It is tempting to look at Low Dose Naltrexone (LDN) and see a single medication capable of addressing
MCAS
The Layered Approach to Mast Cell Activation Syndrome: Integrating Dr. Afrin’s Framework with Functional Medicine Therapeutics
www.directintegrativecare.com A Clinical Chapter on Trigger Avoidance, Anaphylaxis Preparedness, Antihistamines, Stabilizers, Antileukotrienes, Omalizumab, LDN, Quercetin, Luteolin, and Methylene Blue in a Stepwise Model Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Abstract Mast Cell Activation Syndrome (MCAS) is a multi-system
luteolin
Luteolin for Mast Cell Activation Syndrome (MCAS) A Natural Mast Cell Stabilizer Worth Understanding
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician www.directintegrativecare.com Medical Disclaimer This article is for educational purposes only and does not constitute medical advice. Supplements can interact with medications and may not be appropriate for all individuals. Always consult a qualified
estrogen
Estrogen and Mast Cell Activation Syndrome (MCAS): Why the Hormonal Connection Matters More Than You Think
Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Medical Disclaimer This article is for educational purposes only and does not constitute medical advice. The information presented here should not replace the clinical judgment of your healthcare provider. MCAS management and hormone therapy decisions
comt
The COMT Gene and Mast Cell Activation Syndrome: Mechanistic Links, Clinical Implications, and the Limits of Current Evidence
www.directintegrativecare.com Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician An integrative review for clinicians and informed clients Medical Disclaimer This article is intended for educational and informational purposes only and does not constitute medical advice. The information presented reflects a review
histamine
The Neuropsychiatric Impact of Histamine Dysregulation in Mast Cell Activation Syndrome
www.directintegrativecare.com Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician When Anxiety Isn’t “Just Anxiety” The Neuropsychiatric Impact of Histamine Dysregulation in Mast Cell Activation Syndrome Medical Disclaimer: This article is intended for educational purposes only and does not constitute medical
ldn
Why Low-Dose Naltrexone Calms Mast Cells: A Mechanistic Review of LDN in Mast Cell Activation Syndrome
www.directintegrativecare.com Yoon Hang Kim, MD, MPH Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Why Low-Dose Naltrexone Calms Mast Cells: A Mechanistic Review of LDN in Mast Cell Activation Syndrome Disclaimer: This article is intended for educational and informational purposes only and does not constitute
MCAS
MCAS - A New Epidemic in Plain Sight
Mast Cell Activation Syndrome (MCAS): A New Epidemic The Common Node of Long COVID, Lyme Disease, Mold Toxicity, and the Modern Chronic Illness Crisis Yoon Hang Kim, MD, MPH | Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician Direct Integrative Care | Membership-Based Integrative Telemedicine | May 2026 ⚠ MEDICAL DISCLAIMER